Noah Editorial
Blog
Timely research perspectives, biotech market signals, and clinical updates in a cleaner long-form reading format.
October 9, 2026
•Research ProgressCD47 Competitive Landscape 2026: Clinical Programs, Safety Signals and Development Strategy
A 2026 CD47 competitive landscape covering clinical programs, safety liabilities, failure analysis, modality differentiation, biomarker strategy, and development implications.
By Linda
October 9, 2026
•Research ProgressCLDN18.2 Drug Pipeline 2026: How to Track Assets, Biomarkers and Development Milestones with AI
A practical 2026 CLDN18.2 pipeline-intelligence tutorial covering asset mapping, biomarker strategies, development stages, zolbetuximab milestones, and modality comparison.
By Linda
October 9, 2026
•Research ProgressEGFR Osimertinib Resistance in NSCLC 2026: Mechanisms, Biomarkers and Combination Strategies
A 2026 translational review of osimertinib resistance in EGFR-mutant NSCLC, covering mechanisms, biomarkers, patient stratification, and next-line strategies.
By Linda
October 9, 2026
•How-toHow to Extract Evidence from Medical Research Papers with AI: Step-by-Step Guide
Learn how to extract structured, source-traceable evidence from medical research papers with AI, including PICO, endpoints, results, safety data, provenance, and QA.
By Linda
October 9, 2026
•Research ProgressHow to Investigate FcRn and Its Competitive Pipeline with AI
A 2026 FcRn target intelligence brief covering approved therapies, Phase III challengers, dosing, durability, safety, and competitive questions in generalized myasthenia gravis.
By Linda
October 9, 2026
•How-toHow to Find Research Gaps from Biomedical Literature with AI: Step-by-Step Guide
Learn how to find and validate real research gaps in biomedical literature with AI, using ctDNA-guided adjuvant treatment in stage II colon cancer as a worked example.
By Linda
October 9, 2026
•How-toHow to Research a Drug Pipeline with AI: From Target Search to Development Milestones
Learn how to research a drug pipeline with AI using a representative EGFR landscape, from asset mapping and milestones to current development status.
By Linda
October 9, 2026
•How-toHow to Update an Existing Literature Review with New Research Using AI
Learn how to update an existing literature review with AI — identify what changed after your evidence cutoff and revise only the sections that need updating.
By Linda
October 9, 2026
•Comparison10 Late-Stage Drugs to Watch in 2026: Phase III Results and Clinical Outlook
Track 10 late-stage drugs to watch in 2026 across Phase III results, approvals, regulatory reviews, safety, and upcoming clinical milestones.
By Linda
October 9, 2026
•Research ProgressIs There Enough Evidence to Study This Research Gap? A Feasibility Check with AI
Learn how to assess whether a biomedical research gap is feasible using AI, with a ctDNA in pancreatic cancer case covering evidence quality, study design, data access, and research readiness.
By Linda
October 9, 2026
•How-toStatistics Checklist for Biomedical Peer Review: How to Review Clinical Research with AI
Use this biomedical statistics checklist to review sample size, endpoints, confidence intervals, missing data, subgroup analyses, survival methods, and reviewer comments with AI support.
By Linda
October 9, 2026
•Research ProgressTIGIT Competitive Landscape 2026: Clinical Failures, Combination Strategies and Development Outlook
A 2026 TIGIT competitive landscape covering clinical programs, molecular formats, Fc strategies, biomarkers, failure analysis, and development implications.
By Linda